Dr. Xiaoyan Shen earned her Doctor of Medicine in 2011 from the Department of Obstetrics and Gynecology at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. She joined the Department of Obstetrics and Gynecology at Peking University People’s Hospital in the same year and currently serves as an Associate Chief Physician. Dr. Shen specializes in gynecologic oncology, with extensive clinical experience in diagnosing and managing gynecologic malignancies. Her research is dedicated to the comprehensive treatment of gynecologic tumors—including ovarian cancer, gestational trophoblastic neoplasia, endometrial cancer, and cervical cancer—encompassing chemotherapy, targeted therapy, and immunotherapy. A particular focus of her work is on advancing therapeutic strategies for ovarian cancer and gestational trophoblastic neoplasia.
Academic Appointments:
• Member, Gynecologic Oncology Expert Committee, Chinese Society of Clinical Oncology (CSCO)
• Member, Precision Medicine Branch for Gynecologic Oncology, Beijing Association of Obstetrics and Gynecology
• Secretary, Chemotherapy Specialty Group, Chinese Research Hospital Association
Her major publications are listed as follows:
1. Shen X, Gu X, Ma R, Li X, Wang J. Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes. Front Cell Dev Biol. 2022 Mar 17;10:772701.
2. Liu Y, Zhang M, Shen X, Xia C, Hu F, Huang D, Weng Q, Zhang Q, Liu L, Zhu Y, Wang L, Hao J, Zh
Dr. Xiaoyan Shen earned her Doctor of Medicine in 2011 from the Department of Obstetrics and Gynecology at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. She joined the Department of Obstetrics and Gynecology at Peking University People’s Hospital in the same year and currently serves as an Associate Chief Physician. Dr. Shen specializes in gynecologic oncology, with extensive clinical experience in diagnosing and managing gynecologic malignancies. Her research is dedicated to the comprehensive treatment of gynecologic tumors—including ovarian cancer, gestational trophoblastic neoplasia, endometrial cancer, and cervical cancer—encompassing chemotherapy, targeted therapy, and immunotherapy. A particular focus of her work is on advancing therapeutic strategies for ovarian cancer and gestational trophoblastic neoplasia.
Academic Appointments:
• Member, Gynecologic Oncology Expert Committee, Chinese Society of Clinical Oncology (CSCO)
• Member, Precision Medicine Branch for Gynecologic Oncology, Beijing Association of Obstetrics and Gynecology
• Secretary, Chemotherapy Specialty Group, Chinese Research Hospital Association
Her major publications are listed as follows:
1. Shen X, Gu X, Ma R, Li X, Wang J. Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes. Front Cell Dev Biol. 2022 Mar 17;10:772701.
2. Liu Y, Zhang M, Shen X, Xia C, Hu F, Huang D, Weng Q, Zhang Q, Liu L, Zhu Y, Wang L, Hao J, Zh